Our Cancer Diagnostics

For oncologists and pathologists

Immunoscore® family assays

By precisely measuring the immune reaction in and around the tumor, Immunoscore® family assays allow the clinician to determine the degree of severity of the patient’s disease and predict the response to treatment, regardless of the cancer stage or the molecular class.

HalioDx envisions that the evaluation of the immune response to tumors will be the new diagnostic standard in Oncology:

  • To guide existing treatment options, as the Immune contexture of tumors largely determine patients clinical outcome
  • To guide the development of single and combined immunotherapies as clinical response is intimately dependent upon tumor immune microenvironment status.

HalioDx range of Cancer Diagnostics